Topic resource collection
Approved comparison material connected to this topic.
5 resourcesRead both sides
ARA-290 vs Cerebrolysin — Neuroprotective Peptides ARA-290 vs Cerebrolysin differ in mechanisms: one targets innate repair pathways, the other delivers brain-derived neurotrophic factors directly. The field of neuroprotective pep…
The field of neuroprotective peptides has exploded over the past decade, yet fewer than 15% of researchers selecting compounds for cognitive or neural repair studies understand the mechanistic gap between erythropoietin-derived p…
Here's the honest answer: Cerebrolysin has been around since the 1950s with hundreds of published studies, yet it still isn't first-line therapy for any neurological condition in most countries. And that tells you something about…
ARA-290 functions through innate repair receptor (IRR) activation, a pathway first identified in 2008 when researchers at the Max Planck Institute demonstrated tissue protection independent of hematopoietic effects. The peptide b…
Mechanism Innate repair receptor (CD131/EPOR) activation → JAK2/STAT3 signaling Exogenous neurotrophic factor mixture (BDNF, NGF, GDNF analogs) → Trk receptor activation ARA-290 activates endogenous pathways; Cerebrolysin supplem…